WATARI, K., SAJIKI, Y., MAEKAWA, N., MURATA, S., OHASHI, K., KATO, Y., . . . OKAGAWA, T. (2022). Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies. Journal of Veterinary Medical Science, 84(1), 6-15. https://doi.org/10.1292/jvms.21-0552
Chicago Style (17th ed.) CitationWATARI, Kei, Yamato SAJIKI, Naoya MAEKAWA, Shiro MURATA, Kazuhiko OHASHI, Yukinari KATO, Satoru KONNAI, Yasuhiko SUZUKI, and Tomohiro OKAGAWA. "Enhancement of Interleukin-2 Production by Bovine Peripheral Blood Mononuclear Cells Treated with the Combination of Anti-programmed Death-ligand 1 and Cytotoxic T Lymphocyte Antigen 4 Chimeric Monoclonal Antibodies." Journal of Veterinary Medical Science 84, no. 1 (2022): 6-15. https://doi.org/10.1292/jvms.21-0552.
MLA (9th ed.) CitationWATARI, Kei, et al. "Enhancement of Interleukin-2 Production by Bovine Peripheral Blood Mononuclear Cells Treated with the Combination of Anti-programmed Death-ligand 1 and Cytotoxic T Lymphocyte Antigen 4 Chimeric Monoclonal Antibodies." Journal of Veterinary Medical Science, vol. 84, no. 1, 2022, pp. 6-15, https://doi.org/10.1292/jvms.21-0552.